FdaApplication
BLA 761285
Identifiers
- fda_app_no: BLA761285
Properties
| Property | Value |
|---|---|
| applicant_name | Amgen Inc. |
| application_type | BLA |
| approval_date | 2023-10-31 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| WEZLANA | USTEKINUMAB-AUUB | 45MG/0.5ML | Injection |
| WEZLANA | USTEKINUMAB-AUUB | 90MG/ML | Injection |
| WEZLANA | — | 45MG/0.5ML | Injection |
| WEZLANA | — | 45MG/0.5ML | Injection |
| WEZLANA | — | 90MG/ML | Injection |
5 products